Hyderabad Will Be Global Life Sciences Hub: Revanth
Revanth Reddy said Telangana is no longer just competing within India, but with top global clusters even as the city has transformed into the world's preferred destination for global capability centre
Hyderabad: Chief Minister A. Revanth Reddy on Tuesday said Hyderabad has the potential to rise from a global vaccine capital to a global life sciences capital, citing investments and policy support for the sector in Telangana.
Inaugurating the 2026 edition of the event, the Chief Minister said BioAsia stood as proof of Hyderabad’s emergence as a life sciences hub and expressed confidence that the event would soon gain international recognition on the lines of the World Economic Forum in Davos.
He attributed the state’s progress to a clear policy framework, availability of skilled human resources and the presence of reputed educational institutions. He also described Hyderabad as a global hub for global capability centres (GCCs), with strengths in research and design.
Referring to recent initiatives, the Chief Minister cited the launch of the Telangana Next-Gen Life Sciences Policy at Davos, expansion of Genome Valley, the rollout of 1Bio for research and innovation, acceleration of the Green Pharma City project and the opening of several GCCs in Hyderabad.
“In the last two years, we have received over ₹73,000 crore in investments in life sciences,” he said, adding that Hyderabad had emerged as a preferred destination for setting up GCCs, designing molecules and drugs, managing clinical analytics, building AI platforms and driving digital manufacturing.
Highlighting the scale of participation at BioAsia 2026, which drew over 4,000 delegates representing 500 leading life sciences companies globally, the Chief Minister said the event could eventually outgrow its name and be recognised as “Bio-World”.
The Chief Minister said Hyderabad had evolved into a stable and future-ready ecosystem. “From bulk drugs to biologics, from manufacturing to innovation, from India to the world, Telangana is moving up the value chain.”
He also presented the Genome Valley Excellence Award to Prof. Bruce Levine of the University of Pennsylvania.
IT and industries minister D Sridhar Babu said the state government had set a target of attracting $25 billion in life sciences investments by 2030 and generating five lakh jobs. The Telangana Next-Gen Life Sciences Policy (2026-2030) aimed to position the state among the top three life sciences clusters globally by the end of the decade, he said.
Sridhar Babu said India was increasingly being recognised as a source of advanced scientific solutions. “Telangana is preparing for this shift — from a manufacturing base to a global centre for innovation, research and advanced drug discovery,” he said.
He noted that Hyderabad was the only Indian city featured in the CBRE Global Life Sciences Atlas alongside established hubs such as Boston, San Francisco, Beijing and Tokyo.
The minister said efforts were underway to strengthen research, innovation and high-end manufacturing through structured interventions, including skill development in emerging areas such as mRNA technology, gene editing and AI-driven drug discovery. He also referred to a dedicated policy to develop Hyderabad as a global medical tourism hub.
“Telangana is ready to collaborate with global industry leaders to shape the next phase of Life Sciences innovation,” he said. The announcements signal the state government’s focus on positioning Hyderabad as a global centre for innovation-led life sciences growth.
